Royal Bank of Canada’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $342K | Buy |
238,957
+233,392
| +4,194% | +$334K | ﹤0.01% | 4421 |
|
|
2025
Q1 | $9K | Sell |
5,565
-2,555
| -31% | -$4.13K | ﹤0.01% | 5799 |
|
|
2024
Q4 | $29K | Buy |
8,120
+1,815
| +29% | +$6.48K | ﹤0.01% | 5449 |
|
|
2024
Q3 | $36K | Sell |
6,305
-753
| -11% | -$4.3K | ﹤0.01% | 5382 |
|
|
2024
Q2 | $33K | Sell |
7,058
-16,792
| -70% | -$78.5K | ﹤0.01% | 5450 |
|
|
2024
Q1 | $194K | Buy |
23,850
+23,307
| +4,292% | +$190K | ﹤0.01% | 4286 |
|
|
2023
Q4 | $3K | Sell |
543
-5,261
| -91% | -$29.1K | ﹤0.01% | 6170 |
|
|
2023
Q3 | $11K | Buy |
5,804
+5,244
| +936% | +$9.94K | ﹤0.01% | 5881 |
|
|
2023
Q2 | $1K | Sell |
560
-2,373
| -81% | -$4.24K | ﹤0.01% | 6509 |
|
|
2023
Q1 | $9K | Sell |
2,933
-5,353
| -65% | -$16.4K | ﹤0.01% | 5969 |
|
|
2022
Q4 | $49K | Buy |
8,286
+7,229
| +684% | +$42.7K | ﹤0.01% | 5419 |
|
|
2022
Q3 | $9K | Buy |
1,057
+277
| +36% | +$2.36K | ﹤0.01% | 5975 |
|
|
2022
Q2 | $6K | Sell |
780
-1,676
| -68% | -$12.9K | ﹤0.01% | 6096 |
|
|
2022
Q1 | $60K | Sell |
2,456
-9,019
| -79% | -$220K | ﹤0.01% | 5492 |
|
|
2021
Q4 | $369K | Buy |
11,475
+3,850
| +50% | +$124K | ﹤0.01% | 4243 |
|
|
2021
Q3 | $341K | Buy |
7,625
+2,448
| +47% | +$109K | ﹤0.01% | 4182 |
|
|
2021
Q2 | $196K | Buy |
5,177
+4,272
| +472% | +$162K | ﹤0.01% | 4619 |
|
|
2021
Q1 | $33K | Sell |
905
-118
| -12% | -$4.3K | ﹤0.01% | 5637 |
|
|
2020
Q4 | $34K | Buy |
+1,023
| New | +$34K | ﹤0.01% | 5267 |
|